Detection of T-regulatory cells has a potential role in the diagnosis of classical Hodgkin lymphoma

被引:24
作者
Bosler, David S. [2 ]
Douglas-Nikitin, Vonda K. [1 ]
Harris, Valerie N. [1 ]
Smith, Marc D. [1 ]
机构
[1] William Beaumont Hosp, Dept Clin Pathol, Coagulat Lab, Royal Oak, MI 48073 USA
[2] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
关键词
Hodgkin lymphoma; T-regulatory cells; flow cytometry; CD152;
D O I
10.1002/cyto.b.20407
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Previous studies have demonstrated an increase in T-regulatory cells in the involved lymph nodes and peripheral blood of patients with Hodgkin lymphoma. Our study examined whether the detection of T-regulatory cells by flow cytometry could distinguish classical Hodgkin lymphoma (CHL) from benign cases and B-cell non-Hodgkin lymphomas (B-NHL). We measured CD4, CD25, and CD152 in 14 CHLs, 2 nodular lymphocyte-predominant Hodgkin lymphomas, 31 B-NHLs, and 54 benign cases. All T-regulatory cell parameters, including percent lymphocytes CD4+/CD152+ and CD4+/CD25+/CD152+, and mean and median CD152 expression in CD4+/CD25+ lymphocytes, were higher in CHL than in B-NHL and benign. Mean CD152 in CD4+/CD25+ lymphocytes distinguished CHL from benign with 79% sensitivity and 100% specificity, and from B-NHL with 71% sensitivity and 90% specificity. Overall, our results show that T-regulatory cells are increased in CHL and their detection may be a useful tool in differentiating CHL from other entities. (C) 2008 Clinical Cytometry Society.
引用
收藏
页码:227 / 235
页数:9
相关论文
共 29 条
[1]   Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells [J].
Alvaro, T ;
Lejeune, M ;
Salvadó, MT ;
Bosch, R ;
García, JF ;
Jaén, J ;
Banham, AH ;
Roncador, G ;
Montalbán, C ;
Piris, MA .
CLINICAL CANCER RESEARCH, 2005, 11 (04) :1467-1473
[2]   Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine [J].
Beyer, M ;
Kochanek, M ;
Darabi, K ;
Popov, A ;
Jensen, M ;
Endl, E ;
Knolle, PA ;
Thomas, RK ;
von Bergwelt-Baildon, M ;
Bebey, S ;
Hallek, M ;
Schultze, JL .
BLOOD, 2005, 106 (06) :2018-2025
[3]   Regulatory T cells in cancer [J].
Beyer, Marc ;
Schultze, Joachim L. .
BLOOD, 2006, 108 (03) :804-811
[4]   Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J].
Curiel, TJ ;
Coukos, G ;
Zou, LH ;
Alvarez, X ;
Cheng, P ;
Mottram, P ;
Evdemon-Hogan, M ;
Conejo-Garcia, JR ;
Zhang, L ;
Burow, M ;
Zhu, Y ;
Wei, S ;
Kryczek, I ;
Daniel, B ;
Gordon, A ;
Myers, L ;
Lackner, A ;
Disis, ML ;
Knutson, KL ;
Chen, LP ;
Zou, WP .
NATURE MEDICINE, 2004, 10 (09) :942-949
[5]   HUMAN IG SUPERFAMILY CTLA-4 GENE - CHROMOSOMAL LOCALIZATION AND IDENTITY OF PROTEIN-SEQUENCE BETWEEN MURINE AND HUMAN CTLA-4 CYTOPLASMIC DOMAINS [J].
DARIAVACH, P ;
MATTEI, MG ;
GOLSTEIN, P ;
LEFRANC, MP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (12) :1901-1905
[6]   Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood [J].
Dieckmann, D ;
Plottner, H ;
Berchtold, S ;
Berger, T ;
Schuler, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) :1303-1310
[7]   Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting [J].
Fromm, Jonathan R. ;
Kussick, Steven J. ;
Wood, Brent L. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 126 (05) :764-780
[8]  
Ichihara F, 2003, CLIN CANCER RES, V9, P4404
[9]   Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege [J].
Ishida, Takashi ;
Ishii, Toshihiko ;
Inagaki, Atsushi ;
Yano, Hiroki ;
Komatsu, Hirokazu ;
Iida, Shinsuke ;
Inagaki, Hiroshi ;
Ueda, Ryuzo .
CANCER RESEARCH, 2006, 66 (11) :5716-5722
[10]   Peeling the onion: NMDA dysfunction as a unifying model in schizophrenia [J].
Javitt, DC .
BEHAVIORAL AND BRAIN SCIENCES, 2003, 26 (01) :93-+